window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : January 13, 2026

  • News
  • About Us
Contact Us

Immunology

  • Biologics & Biosimilars,Biotech,Immunology,Partnerships & Funding,Research & Development

    TECregen raises CHF 10m (EUR 10.7m) seed financing and appoints Dr Bo Rode Hansen as chairman

    TECregen, a biotechnology company focused on thymus regeneration, has completed [...]

    January 8, 2026
  • Biotech,Drug Development,Immunology,Research & Development

    Nucleome Therapeutics nominates first preclinical development candidate for inflammatory diseases

    Nucleome Therapeutics has nominated its first preclinical development candidate, marking [...]

    January 8, 2026
  • Clinical Trials,Immunology,Neurosciences,Precision medicine

    AC Immune interim Phase 2 data suggest ACI-7104.056 may slow Parkinson’s disease progression

      AC Immune SA has reported positive interim results from [...]

    December 11, 2025
  • Drug approval,Drug Development,Immunology

    Saphnelo self-administration recommended for EU approval for systemic lupus

    AstraZeneca has received a positive recommendation from the Committee for [...]

    December 4, 2025
  • Biotech,Immunology,Research & Development,Technology and platforms

    Macomics updates Enigmac platform data and highlights macrophage role in fibrotic disease

    Macomics has released new data supporting the use of its [...]

    November 25, 2025
  • Biologics & Biosimilars,Cell & Gene Therapy,Drug Development,Global health,Immunology

    Terumo BCT and Santersus partner to advance therapeutic apheresis for sepsis treatment

    Terumo Blood and Cell Technologies (Terumo BCT) and Santersus AG [...]

    November 14, 2025
  • Dermatology,Events and Conferences,Immunology,Mental health,Patient Centricity,Pharmaceuticals and therapeutics

    Almirall ImmunoSkin brings experts together to advance treatment of inflammatory skin diseases

    Almirall has hosted the fourth edition of ImmunoSkin, its annual [...]

    November 12, 2025

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Breast cancer tops list of most-studied diseases for fifth consecutive year, Phesi analysis finds
    Categories: Artificial Intelligence, Clinical Development, Clinical Trials, Data Management, Oncology, Research & Development
  • TECregen raises CHF 10m (EUR 10.7m) seed financing and appoints Dr Bo Rode Hansen as chairman
    Categories: Biologics & Biosimilars, Biotech, Immunology, Partnerships & Funding, Research & Development
  • Pharmapack 2026 to return to Paris with focus on GLP-1 therapies and sustainable packaging
    Categories: Drug Delivery & Formulation, Events and Conferences, Manufacturing, Packaging, Sustainability
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top